70
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Metrifonate alters antioxidant levels and caspase activity in cerebral cortex of Wistar rats

, &
Pages 585-590 | Received 11 Mar 2011, Accepted 14 May 2011, Published online: 24 Sep 2011

References

  • Abdi A, Sadraie H, Dargahi L, Khalaj L, Ahmadiani A. 2011. Apoptosis inhibition can be threatening in Aß-induced neuroinflammation, through promoting cell proliferation. Neurochem Res 36:39–48.
  • Ambali SF, Idris SB, Onukak C, Shittu M, Ayo JO. 2010. Ameliorative effects of vitamin C on short-term sensorimotor and cognitive changes induced by acute chlorpyrifos exposure in Wistar rats. Toxicol Ind Health 26:547–558.
  • Blass JP, Cyrus PA, Bieber F, Gulanski B. 2000. Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The Metrifonate Study Group. Alzheimer Dis Assoc Disord 14:39–45.
  • Brown KM, Arthur JR. 2001. Selenium, selenoproteins and human health: A review. Public Health Nutr 4:593–599.
  • Chang CH, Chen CY, Chiou JY, Peng RY, Peng CH. 2010. Astaxanthine secured apoptotic death of PC12 cells induced by beta-amyloid peptide 25-35: Its molecular action targets. J Med Food 13:548–556.
  • Darreh-Shori T, Soininen H. 2010. Effects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer’s disease: A review of recent clinical studies. Curr Alzheimer Res 7:67–73.
  • Devore EE, Grodstein F, van Rooij FJ, Hofman A, Stampfer MJ, Witteman JC, Breteler MM. 2010. Dietary antioxidants and long-term risk of dementia. Arch Neurol 67:819–825.
  • Di Meo S, Venditti P. 2001. Mitochondria in exercise-induced oxidative stress. Biol Signals Recept 10:125–140.
  • Fairweather-Tait SJ, Bao Y, Broadley MR, Collings R, Ford D, Hesketh JE, Hurst R. 2011. Selenium in human health and disease. Antioxid Redox Signal 14:1337–1383.
  • Fonnum F, Lock EA. 2004. The contributions of excitotoxicity, glutathione depletion and DNA repair in chemically induced injury to neurones: Exemplified with toxic effects on cerebellar granule cells. J Neurochem 88:513–531.
  • Grutzendler J, Morris JC. 2001. Cholinesterase inhibitors for Alzheimer’s disease. Drugs 61:41–52.
  • Gupta A, Agarwal R, Shukla GS. 1999. Functional impairment of blood-brain barrier following pesticide exposure during early development in rats. Hum Exp Toxicol 18:174–179.
  • Gupta RC, Milatovic S, Dettbarn WD, Aschner M, Milatovic D. 2007. Neuronal oxidative injury and dendritic damage induced by carbofuran: Protection by memantine. Toxicol Appl Pharmacol 219:97–105.
  • Inestrosa NC, Dinamarca MC, Alvarez A. 2008. Amyloid-cholinesterase interactions. Implications for Alzheimer’s disease. FEBS J 275:625–632.
  • Jiang N, Lu L, Wang T, Zhang L, Xin W, Fu F. 2010. Reduced glutathione attenuates liver injury induced by methyl parathion in rats. Toxicol Mech Methods 20:69–74.
  • Jungermann K, Gardemann A, Beuers U, Ballé C, Sannemann J, Beckh K, Hartmann H. 1987. Regulation of liver metabolism by the hepatic nerves. Adv Enzyme Regul 26:63–88.
  • Karademir Catalgol B, Ozden S, Alpertunga B. 2007. Effects of trichlorfon on malondialdehyde and antioxidant system in human erythrocytes. Toxicol In Vitro 21:1538–1544.
  • Kostromytska OS, Buss EA. 2008. Seasonal phenology and management of Tomarus subtropicus (Coleoptera: Scarabaeidae) in St. Augustinegrass. J Econ Entomol 101:1847–1855.
  • Lopes WD, dos Santos TR, Borges Fde A, Sakamoto CA, Soares VE, Costa GH, Camargo G, Pulga ME, Bhushan C, da Costa AJ. 2009. Anthelmintic efficacy of oral trichlorfon solution against ivermectin resistant nematode strains in cattle. Vet Parasitol 166:98–102.
  • Liu CY, Chang PA, Wu YJ. 2009. Trichlorfon induces apoptosis in SH-SY5Y neuroblastoma cells via the endoplasmic reticulum? Chem Biol Interact 181:37–44.
  • Liu L, Ikonen S, Heikkinen T, Tapiola T, van Groen T, Tanila H. 2002. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice. Exp Neurol 173:196–204.
  • López-Arrieta JM, Schneider L. 2006. Metrifonate for Alzheimer’s disease. Cochrane Database Syst Rev 2: CD003155.
  • Milatovic D, Gupta RC, Aschner M. 2006. Anticholinesterase toxicity and oxidative stress. ScientificWorldJournal 6:295–310.
  • de Moura MB, dos Santos LS, Van Houten B. 2010. Mitochondrial dysfunction in neurodegenerative diseases and cancer. Environ Mol Mutagen 51:391–405.
  • Pickrell AM, Fukui H, Moraes CT. 2009. The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation. J Bioenerg Biomembr 41:453–456.
  • Pohanka M, Hrabinova M, Kuca K. 2008. Diagnosis of intoxication by the organophosphate VX: Comparison between an electrochemical sensor and Ellman’s photometric method. Sensors 8:5229–5237.
  • Pohanka M, Bandouchova H, Sobotka J, Sedlackova J, Soukupova I, Pikula J. 2009. Comparison of ferric reducing antioxidant power and square wave voltammetry for assay of low molecular weight antioxidants in blood plasma: Performance and comparison of methods. Sensors 9:9094–9103.
  • Pohanka M, Sobotka J, Jilkova M, Stetina R. 2011. Oxidative stress after sulfur mustard intoxication and its reduction by melatonin: Efficacy of antioxidant therapy during serious intoxication. Drug Chem Toxicol 34:85–91.
  • Pohanka M, Novotny L, Karasova JZ, Bandouchova H, Zemek F, Hrabinova M, Misik J, Kuca K, Bajgar J, Zitka O, Cernei N, Kizek R, Pikula J. 2011a. Asoxime (HI-6) impact on dogs after one and tenfold therapeutic doses: Assessment of adverse effects, distribution, and oxidative stress. Environ Toxicol Pharmacol DOI: 10.1016/j.etap.2011.03.014.
  • Pohanka M, Sobotka J, Stetina R. 2011b. Sulfur mustard induced oxidative stress and its alteration by epigallocatechin gallate. Toxicol Lett 201:105–109.
  • Pryor WA, Stanley JP. 1975. Letter: A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. J Org Chem 40:3615–3617.
  • Rakonczay Z, Papp H. 2001. Effects of chronic metrifonate treatment on cholinergic enzymes and the blood-brain barrier. Neurochem Int 39:19–24.
  • Ringman JM, Cummings JL. 1999. Metrifonate: Update on a new antidementia agent. J Clin Psychiatry 60:776–782.
  • Sinha C, Shukla GS. 2003. Species variation in pesticide-induced blood-brain barrier dysfunction. Hum Exp Toxicol 22:647–652.
  • Tian Y, Dai F, Shen L, Feng Y, Gao Y, Xu L, Han S, Shen X. 2009. The effects of trichlorfon on maternal reproduction and mouse embryo development during organogenesis. Ind Health 47:313–318.
  • Yin H, Porter NA. 2005. New insights regarding the autoxidation of polyunsaturated fatty acids. Antioxid Redox Signal 7:170–184.
  • Zaja-Milatovic S, Gupta RC, Aschner M, Milatovic D. 2009. Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist. Toxicol Appl Pharmacol 240:124–131.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.